SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Ranfac CEO Harlan Adler discusses the company's strategic pivot from contract manufacturing to owning cl...
SmartTRAK interviews two HYFACOL Limited executives about their collagen manufacturing platform, HyFaCol...
An interview with ImageBiopsy Lab’s CEO Reinhard Krickl. In an interview with SmartTRAK, Reinhard Krickl...
Ferdinand Hui, MD, discusses the endovascular treatment of cerebral venous disorders, a potentially vast...
SmartTRAK discusses the Soft Tissue Replacement Market landscape and what to expect in 2026. As technolo...
The 2026 cartilage replacement market is moving away from "one-size-fits-all" solutions toward a diversi...
SmartTRAK highlights three neurointerventional trends to watch in 2026. SmartTRAK highlights recent news...
SmartTRAK interviews two leaders from the Alliance of Wound Care Stakeholders to discuss its aim to be t...
SmartTRAK discusses the ambulatory surgery center (ASC) migration – a multi-billion-dollar redistributio...
SmartTRAK Launches New Software and Service Solutions, Creating a Unified "Smart" Insights Platform for ...
Abbott‘s VP of Neuromodulation Ryan Lakin discusses his vision for neuromodulation and trends in the mar...
SmartTRAK highlights four wound companies to watch in 2026 with new-generation antimicrobial alternative...
The American College of Foot & Ankle Surgeons (ACFAS) is once again bringing together the leading cl...
We are pleased to announce that Kent Pendleton has joined the SmartTRAK team as Senior Director of Spine...
SmartTRAK discusses market trends in the Soft Tissue Fixation space, including key developments to watch...
SmartTRAK reviews how the changes to skin substitute reimbursement reforms may impact each site of servi...
SmartTRAK looks at what’s shaping existing devices and what’s new in the US External Wound Care Devices ...
Throughout 2025, SmartTRAK empowered MedTech professionals to Be The Expert by providing timely, data-dr...
SmartTRAK interviews Suneet Varma, CEO of INTENT Biologics, to discuss the company’s novel exosome techn...
Theradaptive’s Chief Scientific Officer Frank Vizesi provides an overview of the company’s unique protei...
SmartTRAK spoke with the Westbrook Weaver, CEO of Tempo Therapeutics, to discuss the company’s new techn...
The North American Neuromodulation Society (NANS) is once again bringing together the leading clinicians...
Chance Leonard and R. Sean Churchill, MD, MBA, of Genesis Innovation Group and Capitan Orthopedics, disc...
The Musculoskeletal New Ventures Conference meeting offers a glimpse into emerging and promising technol...
This SmartTRAK interview features a panel of experts discussing the clinical shift in hip preservation t...
The high costs and complexity involved in manual manufacturing hinder the commercial viability of regene...
Dr. Silverman discusses key takeaways from the AOFAS meeting, along with insights into his practice's sh...
Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of the fina...
Leo Smit, CEO of Hy2Care, discusses the company's innovative hydrogel platform for articular cartilage r...
Conmed’s Lisa Donnelly, VP of Marketing for US Orthopedics, and Jeff Ott, Director of R&D, discuss t...
Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of the fina...
Stephania Bell, a licensed physical therapist, ESPN senior writer, and renowned sports injury analyst, b...
Incoming ICRS President Dr. Christian Lattermann discusses the future of cartilage repair in an intervie...
Raul Nogueira, MD, discusses the latest research and innovation in super-bore catheters for the treatmen...
SmartTRAK reviews the evolving trauma startup landscape in 2025, spotlighting five innovators, followed ...
TOBI President Michael Khadavi, MD, shares his thoughts on the institute's future, key insights from thi...
Dr. Brian Cole discusses the novel OSSIO Kneebar procedure in an interview with SmartTRAK at OSET 2025 i...
It is with both gratitude and admiration that we announce the retirement of Susan Paquette, our former V...
Dr. Steve Sampson, founder of The Orthopedic Institute (TOBI) and the Orthohealing Center, discusses the...
Gregory Berlet, MD, shares insights on trends in foot and ankle surgery, including MIS, ASCs, orthobiolo...
Are you passionate about healthcare and market research? SmartTRAK is looking for talented, self-motivat...
In an interview with SmartTRAK, TendoNova's National Sales Director, Ben Browne, discusses the TendoNova...
Christina Goudy, co-founder and CEO of Reach Orthopaedics, discusses the company and its new subacromial...
SmartTRAK reports from Boston, where discussions about the future of wound care were distracted by signi...
Randy B. Miller, MD shares insights on the history and current state of regenerative medicine, regulator...
We are pleased to announce that Thom Clark has joined the SmartTRAK team as Senior Director, Enterprise ...
SmartTRAK reviews possible alternatives to LCDs and CMS’ proposed payment model for Cellular, Acellular,...
Patient demand, enabling technologies and the ASC shift create a perfect storm for the direct anterior a...
Cerapedics’ CEO Valeska Schroeder discusses the company’s newly PMA-approved PearlMatrix P-15 Peptide En...
James Voos, MD, chair of the Department of Orthopedics and Sports Medicine at University Hospitals Cleve...
SmartTRAK's industry experts discuss CMS’ proposed changes to skin substitutes reimbursement and their p...
Nicolas Piuzzi, MD, discusses the upcoming 2025 Robotic Orthopedic Concepts and Knowledge Symposium (ROC...
Stewart Strong, Q’Apel Medical’s recently appointed CEO, discusses the company, his priorities and plans...
SmartTRAK reviews CMS’ new WISeR model and its potential impact on the US Skin Substitutes Market. A new...
NASS Executive Director and CEO Eric Muehlbauer discusses NASS’s new Innovation NetWORK Summit in an int...
SmartTRAK is excited to attend the Society of Neurointerventional Surgery’s (SNIS) 22nd Annual Meeting &...
Spinal Simplicity’s Chief Strategy Officer Neil P. Dougherty shares how the company is advancing minimal...
SmartTRAK provides insights into the latest trends, research and consensus opinions in surgical Orthobio...
Nearly half a billion in US dollars has been invested in Advanced Wound Care over the last 18 months. Le...
SmartTRAK, the leading provider of actionable market intelligence for orthopedic companies, and Foot Inn...
Scientia Vascular CEO Rick Randall discusses the company, its novel technology and plans for growth in a...
Dr Cheryl Blanchard, president and CEO of Anika Therapeutics, discusses the company, technology and deve...
Companies breathe a temporary sigh of relief as the FDA reissues its guidance documents that could reduc...
Caroline Fife, MD, CMO of Intellicure and Executive Director of the US Wound Registry, discusses real-wo...
SmartTRAK spotlights OSSIO in an interview at AANA 2025 in Washington, DC. Bryan Jones, vice president o...
Nitric Oxide (NO) has numerous benefits for wound healing but has challenges associated with its deliver...
SmartTRAK spotlights Pristine Surgical in an interview at AANA 2025 in Washington, DC. Bryan Lord, CEO o...
Thomas Lash, COO and co-founder of Aatru Medical, talks about the company’s innovative single-use negati...
Tom Borg discusses ZuriMED and its new FDA-cleared product, FiberLocker, in an interview with SmartTRAK ...
VISIE CEO Doug Fairbanks discusses the company’s 3D scanning technologies and its vision for the future ...
Allumin8 CEO Alyssa Huffman discusses the company's novel therapeutic hardware during an interview with ...
SmartTRAK highlights Surgical Theater and its novel 3D visualization technology at ISASS 2025. Dennis Ro...
SmartTRAK spotlights CytexOrtho, the AAOS 2024 OrthoPitch winner, as it develops its biodegradable impla...
SmartTRAK discusses the latest technologies disrupting the standard of care for chronic low back pain (C...
SmartTRAK discusses key products and compelling clinical evidence that may impact the Bone Replacement M...
Perfuze CEO Wayne Allen discusses the company, its novel technology and how the company plans to capture...
SmartTRAK spotlights SentryX, a clinical-stage biopharmaceutical company developing a non-opioid platfor...
Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of delay an...
SmartTRAK highlights AAOS’ OrthoPitch 2025 finalists. Innovation has always been a key growth driver in ...
Soft tissue and cartilage repair trends and innovations take center stage. Joint restoration and preserv...
Recently, SmartTRAK's VP of Sales, Joe Mish, sat down with the Alpha Sophia podcast to discuss the impac...
We are pleased to announce that David Shepard has joined the SmartTRAK team as Senior Analyst, Orthobiol...
SmartTRAK spotlights Tetrous in an interview at AAOS 2025 in San Diego. Andy Carter, Chief Technology Of...
We are pleased to announce that Elizabeth Anderson has joined the team at SmartTRAK as Senior Analyst, B...
CAMPs 2025 meeting highlights the use of CAMPs in all sites of care. SmartTRAK reports the latest news a...
SmartTRAK highlights four wound diagnostics companies utilizing artificial intelligence to watch in 2025...
SmartTRAK delves into recent spinal implant divestitures. The global Spinal Implant Market has seen an i...
SmartTRAK spotlights Doron Therapeutics in an interview with CEO Alessandra Pavesio at CG 2025 Musculosk...
SmartTRAK will be attending AAOS 2025 this week. Join us at AAOS to explore our solution and discuss our...
SmartTRAK highlights the key trends in the US Arthroscopic Technologies Market that will drive growth in...
SmartTRAK highlights game-changing trends in orthobiologics for 2025 and beyond. SmartTRAK highlights tr...
SmartTRAK highlights the key trends in the US Compression Therapy market that will drive growth over the...
SmartTRAK’s new global procedure and brand share analytics tools for the hip and knee markets transform ...
Dr. Marc Russo discusses his research on ultra-low frequency SCS and its potential to treat nociceptive ...
SmartTRAK discusses market trends, including future potential market disrupters. The FY24E US Total Join...
SmartTRAK is attending the upcoming North American Neuromodulation Society meeting (NANS) in Orlando, Fl...
Carsten Schroeder, president and CEO of Terumo Neuro, discusses the company’s plans to capture share and...
In 2024, SmartTRAK continued to empower you to Be The Expert in the MedTech industry. As your trusted re...
SmartTRAK discusses market trends and movement in 2025. The FY24E US Surgical Matrices Market is expecte...
SmartTRAK reports from the recent Wounds UK conference and discovers optimistic resilience in the face o...
SmartTRAK looks at the market’s response to the recently finalized LCDs and the potential impact on the ...
Q’Apel Medical CEO Jodie Fam discusses the company, strategies for growth and Q’Apel’s approach to innov...
The popularity of direct anterior approach THA is driving new product introductions. With the exploding ...
In an interview with SmartTRAK, Gennaro Broya de Lucia, president of the National Board of Directors at ...
Dr. Chris Jeffery, founder and CEO of Convergence Medical, discusses the V01, the world's first arthrosc...
SmartTRAK examines the market dynamics, innovations and growth drivers for Negative Pressure Wound Thera...
New spine technologies "pushed the envelope" at MNVC The Musculoskeletal New Ventures Conference (MNVC) ...
SmartTRAK’s suite of solutions for procedure and brand share analytics will provide orthopedics, wound c...
SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. The Europ...
Medtech companies can learn from Pharma’s evidence-based success to evolve their business strategies, ex...
Technological advances, new market entrants and novel technology continue to make waves at NASS 2024. Sm...
SmartTRAK reports on the latest research and product trends that could potentially impact the market at ...
New products and clinical data continue to grow the spinal hardware and bone replacement markets. The No...
SmartTRAK takes a look at trends impacting the MIS Spine market. The seventeenth Society of Minimally In...
In an interview with SmartTRAK, Dr. Willi Schnorpfeil, an expert in reimbursement strategies, offers a c...
SmartTRAK is attending the upcoming North American Spine Society (NASS) meeting being held Sept. 25-28 i...
SmartTRAK is attending the upcoming North American Spine Society (NASS) meeting being held Sept. 25-28 i...
SmartTRAK reports the latest research and innovation in interventional pain management from ASPN 2024. I...
SmartTRAK is attending the upcoming North American Spine Society (NASS) meeting being held Sept. 25-28 i...
SmartTRAK takes a look at recent trends impacting the Foot & Ankle market. As the first half of 2024...
The 2024 HealthpointCapital Investor Day is taking place on Friday, Sept. 13 in Las Vegas, and SmartTRAK...
SmartTRAK is attending the upcoming American Orthopaedic Foot & Ankle Society Meeting (AOFAS), being...
Amaza Reitmeier, Medtronic’s VP and GM of Brain Modulation, discusses the company’s recent FDA approvals...
SmartTRAK's Anne Staylor, VP & GM Neuro Therapies, will be attending ESMINT 2024 SmartTRAK is excite...
Dr Stephen Snyder, MD, a renowned arthroscopic surgeon who now serves as the Medical Director for Pristi...
Andrew S. Murtha, MD addresses the controversy surrounding kinematic vs mechanical alignment in total kn...
Ariel Sutton, EVP and GM of Imperative Care’s Stroke business, discusses the Imperative Trial, the compa...
New partnership helps clients find and engage with physicians to accelerate product adoption and complem...
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg...
Recent patent applications reveal an industry focus on developing acetabular solutions While enabling te...
Artificial Intelligence (AI) is transforming the medical device industry in myriad ways including enhanc...
We are pleased to announce that John Hatchell has joined the team at SmartTRAK as Director of Sales for ...
ASPN Chairman Tim Deer, MD, discusses the research and innovation at ASPN 2024 and the society’s collabo...
Meet with SmartTRAK in Denver The American Orthopedic Society for Sports Medicine (AOSSM) will hold its ...
Meet with SmartTRAK in Miami! The American Society of Pain and Neuroscience (ASPN) will be holding its 6...
Companies riding the wave of tuck-in acquisitions. While the chances are relatively low that the Total J...
The proposed MAC LCDs for Skin Substitutes/CTPs was the hot topic of SAWC and will continue to be until ...
INS President Dr. Marc Russo and INS President-Elect Dr. Konstantin Slavin discuss the current “state of...
SmartTRAK highlights four key trends to watch in orthopedic enabling tech displayed at the 2024 AAOS and...
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/C...
SmartTRAK highlights market and technology trends that will help drive growth in neurovascular intervent...
ISASS’s Morgan Lorio, MD, president-elect, discusses the obstacles to adopting emerging technologies in ...
New offering delivers wound care companies with actionable data and analytics on wound care treatments, ...
New leadership at Vaporox to launch a second generation of vaporous hyperoxia therapy at SAWC Spring 202...
Medtronic’s David Carr, VP & GM, Pain Interventions, discusses Inceptiv closed-loop SCS in an interv...
SmartTRAK highlights three innovative start-ups with next-gen spine robots in development: Cyber Surgery...
Antimicrobial resistance (AMR) was directly responsible for 1.27 million deaths worldwide in 2019, accor...
SmartTRAK highlights companies to watch as they continue their double-digit growth train with multiple c...
It is difficult to make it as a small to midsize company in the Global Wound Care Market, which was pain...
SmartTRAK highlights key trends and happenings in sports medicine and arthroscopy at AAOS 2024. The Amer...
Adam Hattan, VP of marketing for Route 92 Medical, discusses the SUMMIT MAX trial and provides an update...
SmartTRAK experts across orthopedics, sports medicine, spine and enabling technology attended this year’...
Established and innovative new biologic products share space at Desert Foot 2023. The diabetic populatio...
With many believing that GLP-1 agonists should be considered a “wonder drug,” SmartTRAK explores what im...
SmartTRAK takes a look at the trends impacting the Extremities Market in 2024 and beyond. SmartTRAK prov...
From OEM manufacturers getting dressings approved in the US to pressure injury prevention focus - SmartT...
Rich ongoing data updates and comprehensive expert analyses will deliver evolving market trends and cond...
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, Sm...
Medtronic executives discuss how the Company is making waves in interventional pain, minimally invasive ...
Throughout 2023, SmartTRAK led the way in helping you Be The Expert in the MedTech industry. Serving as ...
Forces likely to influence the Total Joints Market in 2024 Final Q423 US Total Joints Market results are...
SmartTRAK talks with Hybrisan CEO Dr. Mortimer to discuss the challenge of biofilms and the Company’s jo...
SmartTRAK joined industry colleagues in London to explore new technologies at an exciting time in wound ...
MIAMI, FLORIDA — We are thrilled to announce that SmartTRAK's Susan Paquette, VP of Wound Care, will be ...
The North American Neuromodulation Society (NANS) is celebrating its 30th anniversary in 2024 and is onc...
SmartTRAK highlights start-ups developing innovative products for joint resurfacing, soft tissue fixatio...
SmartTRAK attended key sessions on ADM use and reports on the latest trends impacting the US Breast Matr...
Over the last 10+ years, the market for skin substitutes has been turbulent with new technologies and pr...
SmartTRAK was on-site at NASS 2023 covering the latest spine trends including hosting the hottest recept...
Nevro* (NVRO) announced it acquired VYRSA Technologies*, a privately held company focused on the minimal...
Ready to dive into one of the most rapidly expanding markets in the world of Spine? Welcome to the realm...
Three MACs rocked the Skin Substitute/CTP market with changes in coverage in their final LCDs implemente...
SmartTRAK's Elise Wolf, Vice President and General Manager of Orthopedics, Digital and Quality, along wi...
At the 20th World Congress of the International Union of Phlebology, SmartTRAK identifies market develop...
Anika’s President and CEO Cheryl Blanchard, Ph.D., discusses the Company’s expanding portfolio of should...
New SaaS technology offering delivers competitive advantage in rapidly changing Ambulatory Surgery Cente...
SmartTRAK takes a quick look at recent trends that may influence the Total Joints Market in the near and...
Medtronic Neurovascular President Dan Volz discusses expanding patient access to neurovascular therapies...
Fertram Sigurjonsson, CEO of Kerecis, discusses the recent acquisition, how the Company has evolved over...
Increasing acceptance of diagnostics, as well as the repositioning of existing technologies, could help ...
SmartTRAK joined industry colleagues in Boston to explore new technologies at an exciting time in wound ...
SNIS President J Mocco, MD, discusses emerging technologies and new frontiers in neurointervention in an...
SmartTRAK highlights key takeaways from the 2023 AOSSM Meeting As the number of patients seeking treatme...
Csaba Dózsa, habil PhD MSc, Health Economist, discusses his model for cost-effectiveness in the preventi...
SmartTRAK was on-site at ASPN 2023 covering industry-sponsored RCT updates and data reveals, as well as ...
SmartTRAK highlights key takeaways from the 2023 Biologic Association Meeting At the 2023 Annual Meeting...
Samuel Bourdon, Co-Founder and Chief Executive Officer of Statera Medical discusses Statera Medical’s de...
In a joint interview with Eugene Malinskiy, founder and CEO of Lazurite, and orthopedic surgeon Dr James...
SmartTRAK constantly monitors the worldwide MedTech industry, sifting through the noise to present to ou...
Neuromodulation companies are keeping their fingers crossed that the positive growth in Q123 is a sign t...
The Centers for Medicare and Medicaid Services (CMS) projects Medicare home health spending in the US wi...
Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 f...
SmartTRAK’s survey of interventional pain physicians reveals valuable insights into current and future t...
Despite M&A uncertainties with Orthofix/SeaSpine and Globus/NuVasive, the Spine market posted strong...
Orahn Preiss-Bloom, founder and Chief Innovation Officer of Ossio Ltd. discusses Osssio’s advancements i...
SmartTRAK reports from the EWMA conference in Italy, where cold plasma companies are hoping to work toge...
Soft Tissue Fixation Rebounds in Q123 To Start the Year In a Positive Direction In Q1, the STF market ex...
In addition to product innovation and increasing adoption, the Spine Enabling Technology market is rapid...
SmartTRAK highlights cutting-edge advances in non-fusion technologies and motion-preserving treatments p...
US Orthobio market shines bright for the first quarter of 2023. The US Orthobiologics (Orthobio) market ...
Login